Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Infectious Agents and Cancer|June 28, 2008
Clinical and epidemiological correlates of antibody response to human papillomaviruses (HPVs) as measured by a novel ELISA based on denatured recombinant HPV16 late (L) and early (E) antigensColomba Giorgi, Paola Di Bonito, Felicia Grasso, et al.
Infectious Agents and Cancer|December 8, 2006
Serum antibody response to Human papillomavirus (HPV) infections detected by a novel ELISA technique based on denatured recombinant HPV16 L1, L2, E4, E6 and E7 proteinsPaola Di Bonito, Felicia Grasso, Stefania Mochi, et al.
American Journal of Clinical Pathology|June 17, 2010
Up-regulation of lipocalin 2 is associated with high-risk human papillomavirus and grade of cervical lesion at baseline but does not predict outcomes of infections or incident cervical intraepithelial neoplasiaStina Syrjänen, Paulo Naud, Luis Sarian, et al.
American Journal of Clinical Pathology|January 23, 2010
Up-regulation of 14-3-3sigma (Stratifin) is associated with high-grade CIN and high-risk human papillomavirus (HPV) at baseline but does not predict outcomes of HR-HPV infections or incident CIN in the LAMS studyStina Syrjänen, Paulo Naud, Luis Sarian, et al.
American Journal of Clinical Pathology|November 21, 2009
Up-regulation of plasminogen activator inhibitor-2 is associated with high-risk HPV and grade of cervical lesion at baseline but does not predict outcomes of high-risk HPV infections or incident CINStina Syrjänen, Paulo Naud, Luis Sarian, et al.
International Journal of Gynecological Pathology : Official Journal of the International Society of Gynecological Pathologists|March 5, 2008
Predicting high-risk human papillomavirus infection, progression of cervical intraepithelial neoplasia, and prognosis of cervical cancer with a panel of 13 biomarkers tested in multivariate modelingMargherita Branca, Marco Ciotti, Colomba Giorgi, et al.
Bioorganic & Medicinal Chemistry Letters|December 8, 2009
Synthesis and pharmacological characterization of constrained analogues of Vestipitant as in vitro potent and orally active NK(1) receptor antagonistsFabio M Sabbatini, Romano Di Fabio, Cristiana Griffante, et al.
Acta Cytologica|March 7, 2006
Relationship of up-regulation of 67-kd laminin receptor to grade of cervical intraepithelial neoplasia and to high-risk HPV types and prognosis in cervical cancerMargherita Branca, Colomba Giorgi, Marco Ciotti, et al.
Ecancermedicalscience|May 20, 2015
VIN usual type-from the past to the futureMario Preti, Sarah Igidbashian, Silvano Costa, et al.
Gynecologic Oncology|December 23, 2011
Factors predicting the outcome of conservatively treated adenocarcinoma in situ of the uterine cervix: an analysis of 166 casesSilvano Costa, Simona Venturoli, Giovanni Negri, et al.
Pageof 6